Richard H Osborne

ORCID iD
orcid.org/0000-0002-9081-2699
  • Country
  • Show details Hide details
Australia

Sources:
Richard H Osborne (2017-05-03)

  • Keywords
  • Show details Hide details
health literacy, HLQ, flu-iiQ, heiQ

Sources:
Richard H Osborne (2015-02-22)

  • Websites
  • Show details Hide details
http://www.deakin.edu.au/health/research/phi/

Sources:
Richard H Osborne (2015-02-22)

Mendeley profile

Sources:
Elsevier - Mendeley (2017-01-29)

Københavns Universitet profile page

Sources:
PURE (2017-04-05)

  • Other IDs
  • Show details Hide details
ResearcherID: A-9447-2010

Sources:
Clarivate Analytics (2015-01-13)

Scopus Author ID: 7101890122

Sources:
Scopus to ORCID (2015-02-22)

Biography

Osborne is a NHMRC Senior Research Fellow (SRF-B) and holds the Chair of Public Health at Deakin University. He heads the Health Systems Improvement Unit which is a WHO Collaboration Centre for Health Literacy. He holds an Affiliate Professor position at The University of Copenhagen. In 2012, his research program, based on a NHMRC Career Development Award, was recognised by the NHMRC as 1 of the Best 10 Research Projects of 2012. In 2012-13 he was the Director/Co-Director of the Deakin Population Health Strategic Research Centre, a centre with 55 research-only staff. He has over 200 publications and has an H-index of 42 and cited over 20,000 times. An epidemiologist and health services researcher, Osborne has a strong track record in initiating and leading large collaborative research projects. He has initiated and maintained successful collaborative projects across multiple disciplines and has a strong track record of project completion, dissemination and implementation of the results, not only in Australia, but internationally. Research support: As a chief investigator he has received over $20 million in research funding. He has had continuous NHMRC funding since 2004 and has received funds from World Health Organisation (WHO), Australian Research Council, Australian Government Department of Health and Ageing, Victorian Department of Health, beyondblue, RACGP, German Ministry for Health & Education, Thai Ministry for Health, Canadian Institute of Health Research, and US National Institutes of Health. With the Victorian Government Department of Health he led the development of the Ophelia (OPtimising HEalth LIteracy and Access), process, now used in several parts of the world, including in WHO National Health Literacy Demonstration Projects. His team developed the Health Literacy Questionnaire (HLQ) been taken up in over 20 countries across 200 users in 2.5 years. The HLQ is in the upcoming Australian and New Zealand National Health Surveys. In 2015, with the WHO South East Asia Regional Office, he published the Health Literacy Toolkit for Low- and Middle-income countries. At the invitation of the WHO, he has undertaken health literacy capacity building in several regions. In 2016 he was appointed Facilitator of WHO's Global Coordination Mechanism for Noncommunicable Diseases Global Health Literacy Working Group, and is facilitating a global Community of Practice on health literacy. He initiated and led the reform of public waiting lists for hip and knee replacement surgery in Victoria in partnership with the Victorian Government and with senior clinical colleagues. Osborne is a chief investigator on self-management trials in arthritis, psoriasis, HIV, diabetes, stroke, people with multiple complex conditions, and users of health technology. His team has led the creation of several widely licensed products that are having substantial and international impacts on public health: heiQ, MAPT, HLQ, FluiiQ, CHAT, Org-HLR, eHLQ. Collaborations: His collaborations span Asia, Africa, Middle East, USA and Europe. The productivity of these is evidenced by 50% of his published papers in the past 5 years include international authors. With Copenhagen University he initiated the development of a dual Deakin-Copenhagen University PhD degree. He developed the Influenza Intensity and Impact Questionnaire (FluiiQ™) www.fluiiq.com which has been translated to over 30 language variants and is used in global trials of influenza vaccines and anti-virals as a primary or secondary outcome measure assisting with decisions about product effectiveness in trials costing 100s of $millions. As with all his questionnaires, this tool meets or exceeds the stringent FDA requirements. This tool is the primary patient reported outcomes tool used globally and is managed by Measured Solutions for Health P/L an independent private company established and owned by Prof Osborne. Supervision and mentoring: Osborne has supervised 20 higher degree students, including 6 PhDs to completion and currently supervises 5 PhD scholars. He mentors future public health leaders in Nepal, Thailand, Indonesia, Cameroon and Denmark. He welcomes approaches from highly skilled and ambitious individuals seeking to impact on health inequalities either through Fellowships of PhD research scholar programs.
  • : , ,

    {{group.getActive().startDate.year}}-{{group.getActive().startDate.month}}-{{group.getActive().startDate.day}} to present {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}}
     ()
    Source: {{(group.getActive().sourceName == null || group.getActive().sourceName == '') ? group.getActive().source : group.getActive().sourceName}}
    Created:
No education added yet
  • : , ,

    {{group.getActive().startDate.year}}-{{group.getActive().startDate.month}}-{{group.getActive().startDate.day}} to present {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}}
     ()
    Source: {{(group.getActive().sourceName == null || group.getActive().sourceName == '') ? group.getActive().source : group.getActive().sourceName}}
    Created:
No employment added yet
No publications added yet